Compare $ACUT vs $JSPR | Chartloom

Compare

$ACUT vs $JSPR

Accustem Sciences Inc · Jasper Therapeutics Inc

ACUT

Accustem Sciences Inc

JSPR

Jasper Therapeutics Inc

Compare $ACUT vs $JSPR

Comparing Accustem Sciences Inc and Jasper Therapeutics Inc

ACUTAccustem Sciences Inc

JSPRJasper Therapeutics Inc

ACUTAccustem Sciences Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-75.6%

52W performance

-67.3%

FCF yield

-50.9%

JSPRJasper Therapeutics Inc

Market cap

$19M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.0%

52W performance

-76.2%

FCF yield

-318.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACUT

JSPR

Detailed metrics comparison

ACUT

Accustem Sciences Inc

JSPR

Jasper Therapeutics Inc

Market Cap

ACUT$2M

JSPR$19M

Enterprise Value

ACUT$2M

JSPR$12M

Price

ACUT$0.15

JSPR$0.57

P/E Ratio

ACUTN/A

JSPRN/A

P/S Ratio

ACUT0.00x

JSPR0.00x

EV/Sales

ACUT0.00x

JSPR0.00x

EV/EBITDA

ACUT0.00x

JSPR0.00x

P/B Ratio

ACUT2.97x

JSPR13.31x

P/FCF Ratio

ACUTN/A

JSPRN/A

EV/FCF

ACUT-2.01x

JSPR-0.19x

PEG Ratio

ACUTN/A

JSPRN/A

Forward P/E (NTM)

ACUTN/A

JSPRN/A

Forward P/S (NTM)

ACUTN/A

JSPRN/A

Revenue (TTM)

ACUT$0

JSPR$0

Revenue Growth (YoY)

ACUTN/A

JSPRN/A

Forward Rev Growth

ACUT0.0%

JSPR-81.1%

Gross Margin (TTM)

ACUT0.0%

JSPR0.0%

Operating Margin (TTM)

ACUT0.0%

JSPR0.0%

EBITDA Margin (TTM)

ACUT0.0%

JSPR0.0%

Net Margin (TTM)

ACUT0.0%

JSPR0.0%

FCF Margin (TTM)

ACUTN/A

JSPRN/A

Net Income (TTM)

ACUT$-2M

JSPR$-32M

FCF (TTM)

ACUT$-1M

JSPR$-60M

EPS (TTM)

ACUT-$0.10

JSPR-$1.11

ROE (TTM)

ACUT-21712.9%

JSPR-61887.0%

ROA (TTM)

ACUT-10530.0%

JSPR-10067.0%

ROIC (TTM)

ACUT-179413.5%

JSPR-61887.0%

Cash

ACUT$13K

JSPR$7M

Debt

ACUT$63K

JSPR$0

Net Cash/Debt

ACUT$-50K

JSPR$7M

Current Ratio (TTM)

ACUT0.02x

JSPR1.48x

Quick Ratio (TTM)

ACUT0.00x

JSPR1.02x

Debt/Equity (TTM)

ACUT0.27x

JSPR0.00x

Debt/Assets (TTM)

ACUT0.0%

JSPR0.0%

Interest Coverage (TTM)

ACUTN/A

JSPRN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

JSPR0.00x

Beta

ACUT1.88

JSPR3.37

52W Performance

ACUT-67.3%

JSPR-76.2%

YTD Performance

ACUT-75.6%

JSPR-69.0%

% from 52W High

ACUT-93.7%

JSPR-78.8%

% from 52W Low

ACUT26.0%

JSPR81.0%

Asset Turnover (TTM)

ACUT0.00x

JSPR0.00x

FCF Yield (TTM)

ACUT-50.9%

JSPR-318.0%

Earnings Yield (TTM)

ACUT-69.8%

JSPR-167.5%

Dividend Yield (TTM)

ACUTN/A

JSPRN/A

Rule of 40

ACUT0.0

JSPR0.0

EV/GP/RG

ACUTN/A

JSPRN/A

Ticker research

View ACUT research View JSPR research

Metric	ACUT Accustem Sciences Inc	JSPR Jasper Therapeutics Inc
Market & Valuation
Market Cap	$2M	$19M
Enterprise Value	$2M	$12M
Price	$0.15	$0.57
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.97x	13.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-0.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	-81.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-2M	$-32M
FCF (TTM)	$-1M	$-60M
EPS (TTM)	-$0.10	-$1.11
ROE (TTM)	-21712.9%	-61887.0%
ROA (TTM)	-10530.0%	-10067.0%
ROIC (TTM)	-179413.5%	-61887.0%
Financial Health
Cash	$13K	$7M
Debt	$63K	$0
Net Cash/Debt	$-50K	$7M
Current Ratio (TTM)	0.02x	1.48x
Quick Ratio (TTM)	0.00x	1.02x
Debt/Equity (TTM)	0.27x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	3.37
52W Performance	-67.3%	-76.2%
YTD Performance	-75.6%	-69.0%
% from 52W High	-93.7%	-78.8%
% from 52W Low	26.0%	81.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-50.9%	-318.0%
Earnings Yield (TTM)	-69.8%	-167.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACUT research	View JSPR research

Valuation

P/S Ratio

ACUT

0.00x

JSPR

0.00x

EV/FCF

ACUT

-2.01x

JSPR

-0.19x

Growth & revenue

Forward Revenue Growth

ACUT

0.0%

JSPR

-81.1%

Profitability & performance

Gross Margin

ACUT

0.0%

JSPR

0.0%

ROE

ACUT

-21712.9%

JSPR

-61887.0%

FCF Yield %

ACUT

-50.9%

JSPR

-318.0%

52-Week Performance

ACUT

-67.3%

JSPR

-76.2%

Detailed metrics comparison

ACUT

Accustem Sciences Inc

JSPR

Jasper Therapeutics Inc

Market Cap

ACUT$2M

JSPR$19M

Enterprise Value

ACUT$2M

JSPR$12M

Price

ACUT$0.15

JSPR$0.57

P/E Ratio

ACUTN/A

JSPRN/A

P/S Ratio

ACUT0.00x

JSPR0.00x

EV/Sales

ACUT0.00x

JSPR0.00x

EV/EBITDA

ACUT0.00x

JSPR0.00x

P/B Ratio

ACUT2.97x

JSPR13.31x

P/FCF Ratio

ACUTN/A

JSPRN/A

EV/FCF

ACUT-2.01x

JSPR-0.19x

PEG Ratio

ACUTN/A

JSPRN/A

Forward P/E (NTM)

ACUTN/A

JSPRN/A

Forward P/S (NTM)

ACUTN/A

JSPRN/A

Revenue (TTM)

ACUT$0

JSPR$0

Revenue Growth (YoY)

ACUTN/A

JSPRN/A

Forward Rev Growth

ACUT0.0%

JSPR-81.1%

Gross Margin (TTM)

ACUT0.0%

JSPR0.0%

Operating Margin (TTM)

ACUT0.0%

JSPR0.0%

EBITDA Margin (TTM)

ACUT0.0%

JSPR0.0%

Net Margin (TTM)

ACUT0.0%

JSPR0.0%

FCF Margin (TTM)

ACUTN/A

JSPRN/A

Net Income (TTM)

ACUT$-2M

JSPR$-32M

FCF (TTM)

ACUT$-1M

JSPR$-60M

EPS (TTM)

ACUT-$0.10

JSPR-$1.11

ROE (TTM)

ACUT-21712.9%

JSPR-61887.0%

ROA (TTM)

ACUT-10530.0%

JSPR-10067.0%

ROIC (TTM)

ACUT-179413.5%

JSPR-61887.0%

Cash

ACUT$13K

JSPR$7M

Debt

ACUT$63K

JSPR$0

Net Cash/Debt

ACUT$-50K

JSPR$7M

Current Ratio (TTM)

ACUT0.02x

JSPR1.48x

Quick Ratio (TTM)

ACUT0.00x

JSPR1.02x

Debt/Equity (TTM)

ACUT0.27x

JSPR0.00x

Debt/Assets (TTM)

ACUT0.0%

JSPR0.0%

Interest Coverage (TTM)

ACUTN/A

JSPRN/A

Net Debt/EBITDA (TTM)

ACUT0.00x

JSPR0.00x

Beta

ACUT1.88

JSPR3.37

52W Performance

ACUT-67.3%

JSPR-76.2%

YTD Performance

ACUT-75.6%

JSPR-69.0%

% from 52W High

ACUT-93.7%

JSPR-78.8%

% from 52W Low

ACUT26.0%

JSPR81.0%

Asset Turnover (TTM)

ACUT0.00x

JSPR0.00x

FCF Yield (TTM)

ACUT-50.9%

JSPR-318.0%

Earnings Yield (TTM)

ACUT-69.8%

JSPR-167.5%

Dividend Yield (TTM)

ACUTN/A

JSPRN/A

Rule of 40

ACUT0.0

JSPR0.0

EV/GP/RG

ACUTN/A

JSPRN/A

Ticker research

View ACUT research View JSPR research

Metric	ACUT Accustem Sciences Inc	JSPR Jasper Therapeutics Inc
Market & Valuation
Market Cap	$2M	$19M
Enterprise Value	$2M	$12M
Price	$0.15	$0.57
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.97x	13.31x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.01x	-0.19x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	-81.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-2M	$-32M
FCF (TTM)	$-1M	$-60M
EPS (TTM)	-$0.10	-$1.11
ROE (TTM)	-21712.9%	-61887.0%
ROA (TTM)	-10530.0%	-10067.0%
ROIC (TTM)	-179413.5%	-61887.0%
Financial Health
Cash	$13K	$7M
Debt	$63K	$0
Net Cash/Debt	$-50K	$7M
Current Ratio (TTM)	0.02x	1.48x
Quick Ratio (TTM)	0.00x	1.02x
Debt/Equity (TTM)	0.27x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.88	3.37
52W Performance	-67.3%	-76.2%
YTD Performance	-75.6%	-69.0%
% from 52W High	-93.7%	-78.8%
% from 52W Low	26.0%	81.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-50.9%	-318.0%
Earnings Yield (TTM)	-69.8%	-167.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ACUT research	View JSPR research